Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit Jan Schuurhuis, Gert J. Ossenkoppele, Michael Heuser et al.|Blood|2018Cited by 1k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemiaYu Liu, Charles G. Mullighan, John Easton et al.|Nature Genetics|2017Cited by 934
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBrian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2008Cited by 719
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistW. Conrad Liles, David C. Dale, Hal E. Broxmeyer et al.|Blood|2003Cited by 717
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Costa Bachas et al.|Blood|2021Cited by 714